Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021

Nov 24, 2011, 06:48 ET from Reportlinker

NEW YORK, Nov. 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021

http://www.reportlinker.com/p0567591/Genomic-Sequencing-Technologies-for-Medicine-Market-Prospects-2011-2021.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

How you can discover commercial opportunities in genomics

How will the genomic sequencing market develop this decade? Our new report shows you that industry and market's revenue potential from 2011 to 2021, discussing its prospects.

This report covers technology to support genomics, with an emphasis on pharma R&D. We aim to save you time and aid your decisions through our research, analysis and discussions.

Our new study shows you revenue prospects for genomic technologies at total world, submarket, company and national levels to 2021. Third-generation sequencing platforms can increase throughput and lower costs. We discuss the commercial potential. 

You will see how new genomic products and services can change the market. We also discuss prospects for established sequencing technologies. Our revenue forecasting and discussions give answers you need.

You will discover prospects for Roche, Illumina, Complete Genomics, Applied Biosystems, Helicos and other specialists - both established and emerging players. We also discuss activities of Pfizer, J&J, Eli Lilly, GSK, sanofi-aventis, Novartis and other pharma leaders.

We help you to assess the genomic sequencing industry's strengths, weaknesses, trends and revenue opportunities to 2021. You will see where those technologies are heading, with many sequencing opportunities in oncology and other areas. 

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Industry and market analysis to help your work - so you won't be left behind

Our report gives you revenue forecasts, growth rates and market shares. We also provide a SWOT/STEP review, analysis of companies, a technological review and opinions from our survey. 

We include 57 tables and charts and a research interview (shown in the accompanying lists). Our study helps you to understand this industry and its potential.

Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021 shows you revenue trends, opportunities and challenges

Our report gives you the following advantages:

• You will receive revenue forecasts to 2021 for the world genomic sequencing market and its main components

• You will receive revenue forecasts to 2021 for genomic sequencing technologies in the leading national markets (US, UK, Canada, Germany, France,Spain, Italy, Japan, China and India)

• You will see revenue prospects to 2021 for leading manufacturers, with discussions of market potential and competition

• You will receive an overview of genomics research, showing the importance of sequencing technologies in pharma and healthcare biotechnology

• You will examine features of sequencing technologies, including third-generation sequencing platforms

• You will assess the activities of the pharma industry in genomics research and the importance of public-private partnerships - industry-academia links

• You will investigate strengths, competition and opportunities influencing the genomic sequencing market from 2011 onwards

• You will review driving and restraining forces in the genomic sequencing market

• You will analyse opportunities and challenges for established companies and those seeking to enter the genomic sequencing market

• You will view opinion from our survey.

That mix of quantitative and qualitative market analysis sets our report apart. Our analysis helps you to stay ahead in commercial knowledge for genomic technologies.

Order our report now to gain industry and market information you need 

Our report can benefit everybody interested in products, services and market analysis for genomic sequencing in pharma, biosciences and diagnostics. We give predictions and answers you need. Don't miss out - please order our report now.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

Table of Contents

1. Executive Summary

1.1 Review of the Genomic Sequencing Market

1.2 Aims, Scope and Format of Report

1.3 Research and Analysis Methods

2. Introduction to Genomes and Genomic Sequencing

2.1 Introduction

2.2 Deoxyribonucleic Acid (DNA)

2.2.1 Introduction to DNA

2.2.2 Genetic Engineering

2.2.3 Forensics

2.2.4 Bioinformatics

2.3 Genomic Sequencing

2.3.1 Introduction

2.3.2 Early Methods of Genomic Sequencing

2.3.3 The History of Genomic Sequencing

2.3.4 High-Throughput Genomic Sequencing

2.3.5 Decline in the Cost of Genomic Sequencing

2.4 Applications for Genomic Research

2.4.1 Rational Design of Pharmaceuticals

2.4.2 Energy and the Environment

2.4.3 Personalised Medicine

2.4.4 Cancer Treatment

2.5 The Impact of Genomics on the Pharmaceutical Industry

2.5.1 Introduction

2.5.2 Pfizer

2.5.3 Johnson & Johnson

2.5.4 GlaxoSmithKline

2.5.5 Sanofi-Aventis

2.5.6 Novartis

2.5.7 AstraZeneca

2.5.8 Roche

2.5.9 Abbott Laboratories

2.5.10 Merck & Co.

2.5.11 Eli Lilly

2.5.12 Bristol-Myers Squibb

3. Genomic Sequencing Technologies and Leading Manufacturers

3.1 Introduction

3.2 Leading Next-Generation Genome Sequencing Technologies, 2011

3.2.1 Pyrosequencing

3.2.2 TruSeq Technology

3.2.3 SOLiD Sequencing

3.2.4 Ion Semiconductor Sequencing

3.2.5 DNA Nanoball Sequencing

3.3 Leading Manufacturers of Genomic Sequencing Technologies, 2011

3.3.1 Roche 454 Life Sciences

3.3.1.1 Genome Sequencer FLX Titanium Series

3.3.2 Illumina

3.3.3 Complete Genomics

3.3.3.1 Complete Genomics' Proprietary Technology

3.3.4 Applied Biosystems

3.3.5 Helicos BioSciences

3.4 The Future of Genomic Sequencing Technologies

3.4.1 Fewer Optics, More Semiconductors

3.4.2 Technology Must Not Out-Pace the Knowledge of Physicians Regarding the Interpretation of Genetic Tests

3.4.3 Will the Majority of Genome Sequencing Machines Be Commercially-Oriented by 2021?

3.4.4 Data May be the Limiting Factor Determining the Future Growth of the Genomic Sequencing Market

4. Overview of the World Genomic Sequencing Market, 2011-2021

4.1 Overview of the Genomic Sequencing Market, 2011-2021

4.2 Effective Cancer Treatment and Prevention is an Important Goal of Genomics Research

4.3 Illumina is the Leading Manufacturer of DNA Sequencing Technologies but Emerging Third-Generation Manufacturers Pose Serious Competition

4.4 Research Continues to be the Leading End-Use Application of Genomic Sequencing Technologies, but Healthcare Will Also be an Important Driver

4.5 The Blockbuster Model of Pharmaceutical R&D Has Serious Deficiencies: Will Slow Change Impede Genomic Medicine?

5. World Market for Genomic Sequencing Technologies, 2011-2021

5.1 The Global Market for Genomic Sequencing Technologies, 2009

5.2 Genomic Sequencing Market, 2010-2015

5.2.1 Next-Generation Sequencing Technologies Will Drive Market Growth

5.3 Genomic Sequencing Market, 2016-2021

5.3.1 Genomics in Healthcare Will Provide Challenges and Opportunities

5.4 End-Use Applications of Genomic Sequencing Technologies, 2009-2021

5.4.1 Applications of Genomic Sequencing Technologies, 2009

5.4.2 Applications of Genomic Sequencing Technologies, 2010-2021

5.5 Market Prospects for Genomic Sequencing Platforms According to Instrument Generation, 2009-2021

5.5.1 Second-Generation Sequencing Technologies Show Significant Potential for Market Growth, 2009-2015

5.5.2 Technological Innovation Will Drive Growth in the Third-Generation Sequencing Market, 2016-2021

5.6 Prospects for the Leading Genomic Sequencing Manufacturers, 2011-2021

5.6.1 Leading Manufacturers of Next-Generation Sequencing Platforms, 2011-2021

5.6.2 The Competition is Due to Intensify as Third-Generation Platforms Enter the Genomic Sequencing Market

6. Leading National Markets for Genomic Sequencing Technologies, 2011-2021

6.1 Leading National Markets for the Sale of Genomic Sequencing Technologies, 2009

6.2 Forecasts for the Sale of Genomic Sequencing Technologies in the Leading National Markets, 2010-2021

6.2.1 The Genomic Sequencing Market in the USA, 2010-2021

6.2.2 The UK Genomic Sequencing Market, 2010-2021

6.2.3 Other Leading European Markets for Genomic Sequencing Technologies, 2010-2021

6.2.4 The Japanese, Chinese and Indian Genomic Sequencing Markets, 2010-2021

7. Analysis of Factors Influencing the Genomic Sequencing Market, 2011-2021

7.1 SWOT Analysis of the Genomic Sequencing Market

7.2 Drivers of the Genomic Sequencing Market

7.2.1 Technological Advances in Genome Sequencing

7.2.2 Genomic Sequencing Has a Wide-Range of Applications

7.2.3 Personalised Medicine

7.2.4 Improved Collaborative Ties between Industry and Academia

7.3 Restraints on the Genomic Sequencing Market

7.3.1 Only a Narrow Subset of Proteins is Currently Studied by Structural Biologists

7.3.2 Reductions in Pharmaceutical R&D Spending Will Have an Adverse Effect on the Genomic Sequencing Market

7.3.3 Lack of Clear Guidelines on How to Harness Genomic Sequencing Technologies in the Healthcare Sector

7.4 Outlook for the Genomic Sequencing Market, 2011-2021

7.4.1 Third-Generation Sequencing Platforms Promise Further Reductions in the Costs of Sequencing

7.4.2 Intellectual Property Disputes Will Slow the Advances in Genomic Sequencing Technologies

7.4.3 Data Storage and Handling May Be the Greatest Limiting Factors Determining the Growth of the Genomic Sequencing Market

8. Opinion from Our Survey

8.1 Interview with Dr Chas Bountra, Chief Scientist and Head of the Structural Genomics Consortium, University of Oxford, UK

8.1.1 Research at the Structural Genomics Consortium

8.1.2 Genomic Sequencing and Pharmaceutical Drug Discovery

8.1.3 The Challenges Facing the Pharmaceutical Industry

8.1.4 A Model of Drug Discovery Based on Greater Collaboration between Academics and Industry

8.1.5 Genomic Sequencing and Personalised Medicines

8.1.6 Outlook for the Future: Looking Towards 2021

9. Outlook for the Genomic Sequencing Market, 2011-2021

9.1 Will Human Genomics Become Part of Everyday 21st Century Life?

9.2 Whole-Genome Sequencing Will Affect the Healthcare Sector by 2021

9.3 The Clinical Impact of Genomics May be Slower than Expected

9.4 The US and UK Dominate the World Genomic Sequencing Market Now, But Other Countries Will Present Increasing Competition

9.5 Promising Third-Generation Sequencing Technologies and Their Manufacturers

9.5.1 PacBio RS Sequencer

9.5.2 Oxford Nanopore Technologies

9.5.3 The Personal Genome Machine (PGM)

9.5.4 Quantum-Dot Based Sequencing

9.5.5 Helicos Genetic Analysis System

10. Conclusions

10.1 The Genomic Sequencing Market Will See Rapid Growth from 2011-2021

10.2 China Has the Potential to Become the World's 'Genome Sequencing Factory'

10.3 Data Storage and Analysis Will Be Defining Issues with the Potential to Limit Future Growth in the Genomic Sequencing Market

10.4 Public-Private Partnerships Are a Key to the Resurgence of Pharmaceutical R&D

List of Tables

Table 2.1 Average Cost ($m) of Sequencing the Human Genome, 2000-2005

Table 2.2 Average Cost ($m) of Sequencing the Human Genome, 2006-2011

Table 2.3 Average Cost ($) of Sequencing the Human Genome, 2012-2017

Table 2.4 Average Cost ($) of Sequencing the Human Genome, 2018-2021

Table 2.5 Structural Genomics Networks and Activities, 2011

Table 3.1 Costs ($m) and Percentage Shares (%) of the Components Involved in Sequencing a Human Genome, 2007

Table 4.1 US Cancer Research Spending ($m) on Specific Cancer Types, 2009-2011

Table 4.2 Forecast Sales Revenues ($bn) and Market Shares (%) for Illumina DNA Sequencing Platforms, 2009-2015

Table 4.3 Forecast Sales Revenues ($bn) and Market Shares (%) for Illumina DNA Sequencing Platforms, 2016-2021

Table 5.1 World Markets ($bn) for Genomic Sequencing Technologies, 2009-2015

Table 5.2 World Markets ($bn) for Genomic Sequencing Technologies, 2016-2021

Table 5.3 Market ($bn) Forecasts for the Sale of Genomic Sequencing Technologies by End-User Application, 2009-2015

Table 5.4 Market ($bn) Forecasts for the Sale of Genomic Sequencing Technologies by End-User Application, 2016-2021

Table 5.5 Market ($bn) Forecasts for the Sale of Genomic Sequencing Technologies by Instrument Generation, 2009-2015

Table 5.6 Market ($bn) Forecasts for the Sale of Genomic Sequencing Technologies by Instrument Generation, 2016-2021

Table 5.7 Revenues ($bn) for the Genomic Sequencing Market by Manufacturer, 2009-2015

Table 5.8 Revenues ($bn) for the Genomic Sequencing Market by Manufacturer, 2016-2021

Table 6.1 Sales ($bn) and Market Shares (%) of Genomic Sequencing Technologies in Leading National Markets, 2009

Table 6.2 Sales ($bn) of Genomic Sequencing Technologies in Leading National Markets, 2009-2015

Table 6.3 Sales ($bn) of Genomic Sequencing Technologies in Leading National Markets, 2016-2021

Table 6.4 Leading National Market Shares (%) for the Global Genomic Sequencing Technologies Market, 2010-2021

Table 7.1 SWOT Analysis of the Pharmaceutical Genomic Sequencing Market, 2011

Table 9.1 National Distribution of Genomic Sequencing Facilities, 2010

Table 9.2 Some Promising Genomic Sequencing Technologies, 2011

List of Figures

Figure 2.1 Average Cost ($m) of Sequencing the Human Genome, 2000-2005

Figure 2.2 Average Cost ($m) of Sequencing the Human Genome, 2006-2011

Figure 2.3 Average Cost ($) of Sequencing the Human Genome, 2012-2017

Figure 2.4 Average Cost ($) of Sequencing the Human Genome, 2018-2021

Figure 3.1 Percentage Shares (%) of the Costs Involved in Sequencing a Human Genome, 2007

Figure 4.1 US Cancer Research Spending ($m) on Specific Cancer Types, 2010

Figure 4.2 Percentage Shares (%) of US Research Spending on Specific Cancer Types, 2010

Figure 4.3 Percentage Shares (%) of US Research Spending on Specific Cancer Types, 2011

Figure 4.4 Sales Revenues ($bn) for Illumina DNA Sequencing Platforms, 2009-2015

Figure 4.5 Sales Revenues ($bn) for Illumina DNA Sequencing Platforms, 2016-2021

Figure 5.1 World Market ($bn) for Genomic Sequencing Technologies, 2009-2021

Figure 5.2 Market Forecasts ($bn) for the Sale of Genomic Sequencing Technologies by End-User Application, 2009-2021

Figure 5.3 Market Shares (%) for the Sale of Genomic Sequencing Technologies by End-User Application, 2010

Figure 5.4 Market Shares (%) for the Sale of Genomic Sequencing Technologies by End-User Application, 2015

Figure 5.5 Market Shares (%) for the Sale of Genomic Sequencing Technologies by End-User Application, 2021

Figure 5.6 Market Forecasts ($bn) for the Sale of Genomic Sequencing Technologies by Instrument Generation, 2009-2021

Figure 5.7 Market Shares (%) for the Sale of Genomic Sequencing Technologies by Instrument Generation, 2011

Figure 5.8 Market Shares (%) for the Sale of Genomic Sequencing Technologies by Instrument Generation, 2016

Figure 5.9 Market Shares (%) for the Sale of Genomic Sequencing Technologies by Instrument Generation, 2021

Figure 5.10 Revenues ($bn) for the Genomic Sequencing Market by Manufacturer, 2009-2021

Figure 5.11 Market Shares (%) for the Leading Genomic Sequencing Manufacturers, 2010

Figure 5.12 Market Shares (%) for the Leading Genomic Sequencing Manufacturers, 2015

Figure 5.13 Market Shares (%) for the Leading Genomic Sequencing Manufacturers, 2021

Figure 6.1 Sales ($bn) of Genomic Sequencing Technologies in Leading National Markets, 2009

Figure 6.2 Leading National Market Shares (%) for the Global Genomic Sequencing Technologies Market, 2010

Figure 6.3 Leading National Market Shares (%) for the Global Genomic Sequencing Technologies Market, 2015

Figure 6.4 Leading National Market Shares (%) for the Global Genomic Sequencing Technologies Market, 2021

Figure 6.5 The US Genomic Sequencing Technologies Market ($bn), 2009-2021

Figure 6.6 The UK Genomic Sequencing Technologies Market ($bn), 2009-2021

Figure 6.7 Other Leading European Markets ($bn) for Genomic Sequencing Technologies, 2009-2021

Figure 6.8 The Japanese, Chinese and Indian Genomic Sequencing Markets ($bn), 2009-2021 

Figure 9.1 Forecast Revenues ($bn) for the Sale of Genomic Sequencing Technologies Used within the Healthcare Sector, 2009-2021

Figure 9.2 National Distribution (%) of Genomic Sequencing Facilities, 2010

Companies Listed

454 Life Sciences

Abbott Laboratories

American Association for Cancer Research

American Medical Association 

Applied Biosystems 

AstraZeneca

AstraZeneca Transgenics & Comparative Genomics Centre

Berkeley Structural Genomics Center

BGI

Brigham & Women's Hospital

Bristol-Myers Squibb

Broad Institute

Celera Genomics

Center for Eukaryotic Structural Genomics

Chinese Academy of Sciences

Complete Genomics

CuraGen

Duke University 

DNA Electronics

Eli Lilly

EpiTherapeutics 

European Membrane Protein Consortium

ExxonMobil

Food and Drug Administration (US FDA)

Genentech 

General Electric (GE)

Genome Analysis Centre

Genomic Science Program

GlaxoSmithKline 

Goldman Sachs 

Helicos BioSciences 

Human Genome Project

IBM

Illumina 

Imperial College London

Institute for Systems Biology

Invesco Perpetual 

Ion Torrent

IP Group

Joint Center for Structural Genomics

Johnson & Johnson

J. Craig Venter Institute 

J.P. Morgan

Lansdowne Partners

Life Technologies

Medco

Medical Council Research Laboratory of Molecular Biology

Medical Research Council (UK)

Membrane Protein Network

Merck & Co.

Microbial Genome Program

Midwest Center for Structural Genomics

Multiple Myeloma Research Foundation 

National Cancer Institute (US)

National Center for Biotechnology Information

National Human Genome Research Institute (US)

National Institutes of Health (US)

National Institutes of Health Chemical GenomicsCenter

New York Structural Genomics Research Consortium

NimbleGen

Northeast Structural Genomics Consortium 

Novartis

Ontario Institute for Biotechnology

Ontario Ministry of Research and Innovation

Oxford Nanopore Technologies

Oxford Structural Genomics Consortium 

Pacific Biosciences

Paris-Sud Yeast Structural Genomics Project

PerkinElmer

Pfizer

Protein Data Bank

Protein Structure Factory

RIKEN Structural Genomics/Proteomics Institute 

Roche

Sage Bionetworks

Sanofi-Aventis

Southeast Collaboratory for Structural Genomics 

Stratified Medicines Innovation Platform

Structural Genomics Consortium

Structure 2 Function Project

Swedish Foundation for Strategic Research

Swiss National Center of Competence in Research

Synthetic Genomics

Synthetic Genomics Vaccines

TB Structural Genomics Consortium

Technology Strategy Board (UK)

The Genome Institute at Washington University

The Institute for Genomic Research

Tufts Center for the Study of Drug Development

Translational Genomics Research Institute 

Umeå University

University of Ghent

University of Oxford

University of Toronto

US Congress

US Department of Energy

US Government

VisiGen

Wall Street Journal

Washington University

Welcome Trust

Welcome Trust Sanger Institute

World Health Organization

To order this report:

: Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021

More  Market Research Report

Check our  Real Time Industry Data

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com